About Dr. Randeep Singh
Dr. Randeep Singh is a Senior Consultant and Director of Medical Oncology with over 20 years of experience in managing complex adult cancers. A Medical Oncologist in Gurgaon, India, he is recognised for delivering personalised, evidence-based care using chemotherapy, targeted therapy and immunotherapy for solid and haemato-lymphoid tumours.
- 20+ years of specialised experience in Medical Oncology
- Trained extensively at Tata Memorial Hospital, Mumbai — India's top cancer centre
- 40+ peer-reviewed publications in national and international oncology journals
- Expert in breast, lung and gastrointestinal cancers
- Regularly treats international patients from the Gulf, Africa and CIS regions
Qualifications & Credentials
Medical Degrees
- MBBS — Bharati Vidyapeeth Deemed University, Pune, 2000
- MD (Paediatrics) — Dr. Sampurnanand Medical College, Jodhpur, 2006
- DNB (Medical Oncology) — Tata Memorial Hospital, Mumbai, 2011
Fellowships & Special Training
- Advanced Medical Oncology Training — Tata Memorial Hospital, Mumbai
- Distinction awarded in Biochemistry, Surgery and Ophthalmology — Bharati Vidyapeeth University, Pune, 2000
Certifications & Accreditations
- Delhi Medical Council / Medical Council of India Registration
- Indian Society of Medical & Paediatric Oncology (ISMPO) — Executive Member
- Indian Cooperative Oncology Network (ICON) — Executive Member
- American Society of Clinical Oncology (ASCO) — Member
- European Society of Medical Oncology (ESMO) — Member
Areas of Expertise
Major Conditions Treated
- Breast Cancer
- Lung Cancer
- Gastrointestinal Cancers (Colorectal, Gastric, Pancreatic)
- Lymphoma (Hodgkin & Non-Hodgkin)
- Leukaemia & Multiple Myeloma
- Head & Neck Cancers
- Genitourinary Cancers (Prostate, Kidney, Bladder)
- Gynaecological Cancers (Ovarian, Cervical, Endometrial)
Sub-specialties
- Precision & Targeted Therapy: Uses biomarker-driven treatment for EGFR, ALK, HER2 and BRAF-positive tumours — a recognised best Medical Oncology doctor in India for molecular-guided cancer care.
- Immuno-Oncology: Delivers checkpoint inhibitor therapies (PD-1/PD-L1) for advanced lung, melanoma and urothelial cancers.
- Haemato-Lymphoid Oncology: Manages complex leukaemias, lymphomas and myeloma with curative-intent chemotherapy protocols.
Advanced Procedures & Treatments
- Intravenous, Intrathecal & Intraperitoneal Chemotherapy
- Targeted Therapy (Tyrosine Kinase Inhibitors, Monoclonal Antibodies)
- Immunotherapy / Checkpoint Inhibitors
- Hormone Therapy (Breast, Prostate Cancer)
- Port-a-Cath Insertion & Central Line Management
- Tumour Marker & Molecular Profiling
- Palliative & Supportive Oncology Care
List of Disease and Treatment for which Dr. Randeep Singh can be consulted
Professional Experience
Current Affiliation
- Narayana Superspeciality Hospital, Gurugram — Director & Senior Consultant, Medical Oncology (Present)
Past Affiliations
- Artemis Hospitals, Gurugram — Senior Consultant & Unit Head, Medical Oncology
- HCG Cancer Centre, Delhi — Head of Department, Medical Oncology
- Max Healthcare, Delhi — Consultant Medical Oncology (~5 years)
- Tata Memorial Hospital, Mumbai — Consultant Medical Oncology
Academic & Research Roles
- Co-Founder Member — International CME Organisation
- Executive Member — Delhi Oncology Forum
- Regular faculty and invited speaker at national & international oncology conferences
Key Achievements
- 40+ publications in peer-reviewed national and international oncology journals
- 20+ years of dedicated clinical practice in medical oncology
- 98% patient recommendation rate based on published feedback
- Extensive experience treating international patients from Gulf, Africa and South Asia
Awards & Recognitions
National & International Awards
- 2nd prize, Haematology Quiz, Indian Cooperative Oncology Network, National Level, 2014
- 1st prize, Neonatology Quiz, National Neonatology Forum, State Level, 2006
- 2nd prize, Paper Presentation, Indian Academy of Paediatrics, State Level, 2006
- Distinction in Biochemistry, Surgery and Ophthalmology — Bharati Vidyapeeth University, 2000
Professional Memberships
- American Society of Clinical Oncology (ASCO)
- European Society of Medical Oncology (ESMO)
- Indian Society of Medical & Paediatric Oncology (ISMPO)
- Indian Cooperative Oncology Network (ICON)
- Delhi Oncology Forum
- Indian Academy of Paediatrics (IAP)
Research & Publications
Published Papers (Selected)
- 40+ original research articles and review papers in national and international oncology journals covering targeted therapy, chemotherapy outcomes, and solid tumour management.
- Regular scientific paper presentations at ASCO, ESMO and ISMPO annual meetings.
- Specific article-level citations: Information not publicly available.
Ongoing Research & Clinical Interests
- Targeted & immunotherapy outcomes in lung and breast cancer
- Molecular profiling for personalised chemotherapy
- Management of haemato-lymphoid malignancies
- Supportive and palliative oncology protocols
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (INR) | Estimated Cost (USD) |
|---|---|---|
| Medical Oncology Consultation | ₹1,500 – ₹3,000 | $18 – $36 |
| Chemotherapy (per cycle, regimen-dependent) | ₹25,000 – ₹1,80,000 | $300 – $2,160 |
| Targeted Therapy (per month, drug-dependent) | ₹60,000 – ₹3,50,000 | $720 – $4,200 |
| Immunotherapy (per cycle) | ₹90,000 – ₹2,80,000 | $1,080 – $3,360 |
| Molecular / Tumour Marker Profiling | ₹8,000 – ₹60,000 | $96 – $720 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Dr. Randeep Singh use in Medical Oncologist treatment?
Dr. Randeep Singh employs molecular profiling, biomarker-driven targeted therapy (EGFR, ALK, HER2, BRAF), checkpoint inhibitor immunotherapy (PD-1/PD-L1), and intravenous, intrathecal and intraperitoneal chemotherapy. He also offers virtual second opinions for international patients reviewing treatment options.
2. What conditions does Dr. Randeep Singh specialize in treating?
Dr. Randeep Singh specialises in managing breast cancer, lung cancer, gastrointestinal cancers (colorectal, gastric, pancreatic), lymphomas, leukaemias, and both solid and haemato-lymphoid tumours — making him a trusted Medical Oncologist in Gurgaon for complex adult cancer care.
3. How do I book an appointment with Dr. Randeep Singh?
Appointments with Dr. Randeep Singh can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Dr. Randeep Singh?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Dr. Randeep Singh, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Dr. Randeep Singh offer second opinions for Medical Oncologist cases?
Yes. Second opinion consultations can be arranged via Cancer Rounds for patients who wish to review their diagnosis or treatment plan with an expert Medical Oncologist specialist in Gurgaon, India.














